The virulence of a deletion variant of herpes simplex virus type 2 (HSV-2) strain HG52 has been determined by intracranial inoculation of 3-week-old BALB/c mice.
INTRODUCTION
The identification of genes involved in viral pathogenicity and the elucidation of their precise functions is of fundamental importance to the understanding of the biology of herpes simplex virus (HSV). Many host factors have been shown to influence virulence including animal age (Kohl & Loo, 1980) , route of inoculation (Caspary et al., 1980) and strain of experimental animal (Lopez, 1975) . Virus strain (Dix et al., 1983) and the consequences of serial passage of virus in vivo (Kaerner et al., 1983) and in vitro (Goodman & Stevens, 1986) have also been implicated.
Mutation in or deletion of the viral thymidine kinase (TK) gene has been shown to impair virulence (Field & Wildy, 1978) and viral sequences between 0-7 and 0.83 map units (m.u.) have been shown to be involved in determining the virulence phenotype (Thompson & Stevens, 1983; Thompson et al., 1985 ; Javier et al., 1986; Rosen et al., 1986) . Sequences between 0.25 and 0-53 m.u. have also been implicated (Thompson et al., 1986) as has the viral DNA polymerase (Field & Coen, 1986) .
We have isolated and characterized a number of variants of both HSV type 1 (HSV-1) (strain 17) and HSV-2 (strain HG52) with defined deletions in the unique and repeat sequences of both the long and short regions of the viral genome (Brown et al., 1984; Harland & Brown, 1985; Brown & Harland, 1987; MacLean & Brown, 1987a, b) . Availability of variants with deletions in specific regions of the viral genome affords a unique opportunity to determine the possible role of specific sequences in both latency and virulence.
Heterogeneity in the neurovirulence of plaque-purified stocks of the parental HSV-2 strain HG52 has recently been reported (Tabu et al., 1988) . A baseline was thus established from which to evaluate the neurovirulence of one variant, JH2604 (HG52XD192) (Harland & Brown, 1985) , which has a deletion of approx. 1.5 kb within each copy of BamHI v (0 to 0-02 and 0-81 to 0.83 m.u.). Restriction endonuclease analysis and the lack of sequencing data for this region of the HG52 genome has not enabled determination of whether totally identical sequences have been removed from both the terminal repeat (TRL) and internal inverted repeat (/RE) or 0000-8661 O 1989 SGM excess with intact DNA from HG52 plaque 17. Resulting individual plaques from cotransfections were isolated and their DNA was analysed by the method of Lonsdale (1979) . Virus which appeared to have acquired the deletion was plaque-purified three times before growing a virus stock.
Thymidine kinase assay. The method used was a modification of that of Jamieson & Subak-Sharpe (1974) . BHK-21 C-13 cells (5 x 105) were mock-infected or infected with wild-type or mutant virus at an m.o.i, of 5 p.f.u./cell. After absorption for 1 h and incubation for 6 h at 37 °C, the cells were scraped into 1 ml cold PBS and pelleted. The pellet was resuspended in 150 ~tl lysis buffer (20 mM-Tris-HCl pH 7-5, 2 m~l-MgCl2, 10 mM-NaC1, 0"5~ v/v Nonidet P40, 6.5 mM-2-mercaptoethanol), maintained on ice for 5 min, mixed briefly and replaced on ice for a further 5 min. The samples were then centrifuged and the supernatant was retained. Five ktl of extract was mixed with the reaction buffer in a total volume of 50 ~tl (0-5 M-Na2PO~ pH 6, 100 mM-MgCI:, 2 mM-dTTP, 100 mM-ATP, 5 p.l aqueous [Me-3H]thymidine 1 mCi/ml). After incubating for 1 h the reaction was stopped by the addition of 10 p.l of 100 mM-EDTA and 1 mM-thymidine. The samples were heated for 3 min at 100 °C and placed on ice for 3 min. After centrifugation, 40 p-1 of the supernatant was spotted onto DE81 discs which were washed three times (10 min each at 37 °C) with 4 m~i-ammonium formate pH 6.0 and 10 ~tM-thymidine. After a further two washes with ethanol, the discs were dried and radioactivity due to [3H]thymidine was determined.
RESULTS

Neurovirulence of the deletion variant JH2604 (HG52XD192) for BALB/c mice
The DNA structure of the deletion variant JH2604 has been described in detail by Harland & Brown (1985) . Essentially the genome bears a deletion of approx. 1-5 kb in both copies of BamHI v, located between 0 to 0.02 and 0.81 to 0-83 m.u. in TRL and IRL respectively. To determine the neurovirulence of this variant compared to the parental HG52 virus, experiments were carried out to estimate the LDs0 values of BALB/c mice. Twenty-five gl aliquots of different doses of HG52 and JH2604 were inoculated into the left cerebral hemisphere of 3-week-old BALB/c mice of each sex. Deaths from encephalitis were scored between day 3 and day 21 postinoculation and the LDso values are shown in Table 1 .
The elite parental stock of HG52 without further plaque purification showed an LDso of < 102 p.f.u, which was comparable to that determined previously and to the LD50 value of < 103 p.f.u, calculated for the plaque-purified, plaque 17 stock of riG52 (Taha et al., 1988) . The LDs0 of JH2604 was greater than 107 p.f.u. ; at doses of 107 p.f.u./animal, only one animal out of nine died and no others showed signs of encephalitis or any other symptoms of illness or distress. Also, two mice infected with 108 p.f.u, of JH2604 remained healthy after inoculation. Thus the deletion variant JH2604 was at least 106-fold less neurovirulent than the parental HG52 virus stock. The particle : p.f.u, ratios of 54 : 1 for HG52 and 71 : 1 for JH2604 are comparable and fall within the normal range of values for HSV-2.
Growth of JH2604 in vivo
To determine whether the low neurovirulence of JH2604 was due to failure of replication in mouse brain, the growth of the virus in vivo was tested. Samples of HG52 and JH2604 (105 p.f.u./mouse) were inoculated into the left cerebral hemisphere of 3-week-old BALB/c mice of each sex. At various times post-infection, two mice were killed and their brains frozen at -70 °C. The brain tissue was homogenized, and the resulting suspension was sonicated and assayed by plaque titration on BHK-21 C-13 cells at 37 °C. The results plotted in Fig. 1 show that the parental HG52 grew well in mouse brain with the titre continuing to rise at 120 h postinoculation; by 144 h all the mice had died from encephalitis. In contrast, the variant JH2604 failed to show significant replication and the titre diminished progressively with time.
Growth of JH2604 in vitro
The deletion variant JH2604 grows like wild-type virus in a single-cycle growth experiment in BHK-21 C-13 cells at 37 °C (Harland & Brown, 1985) ; the parental elite stock of HG52 is somewhat temperature-restricted at 38-5 °C (Brown & Harland, 1987) in that, though displaying exponential growth, the highest titre of virus reached by 12 h post-infection is not appreciably higher than the starting titre immediately post-absorptiom The variant JH2604 is not temperature-sensitive in the classical sense but is impaired in single-cycle growth experiments at 38.5 °C to the same extent as the parental HG52. The titre of the JH2604 stock used for all experiments was 4 x l07 p.f.u./ml at 31 °C and 3 × 107 p.f.u./ml at 38.5 °C.
To determine whether JH2604 was temperature-sensitive in mouse cells at the accepted ambient body temperature of mice, i.e. 38.5 °C, comparative one-step growth experiments were carried out in BALB/c mouse embryo fibroblasts (3T3 cells) at 38.5 °C, and virus yield was titrated on BHK-21 C-13 cells at 37 °C. Results are given in Fig. 2 and show that the parental HG52 initially replicated poorly, reaching a titre comparable to the input titre by 8 h postinfection and then diminishing. The mutant JH2604 showed little evidence of replication and IP: 54.70.40.11
On: Sat, 27 Jul 2019 10:02:59 the virus titre progressively fell with time. I.n a multi-step growth experiment performed at 37 °C in 3T3 cells, again the parental HG52 demonstrated some replication and reached a low peak titre by 24 h post-infection. The variant JH2604 failed to replicate and the infective titre dropped with time (data not shown).
HSV-2 RL sequences are required for virulence
It is concluded that BALB/c 3T3 cells are poor hosts for replication of HSV-2 (HG52) although some replication of wild-type virus does occur; these cells appear to be non-permissive for the deletion variant JH2604 both at 37 °C and 38.5 °C.
Infected cell polypeptide synthesis
It has been shown previously that JH2604 synthesizes normal amounts of the HSV-induced immediate early polypeptides (Harland & Brown, 1985) . To determine whether the deletion in JH2604 affected any other polypeptide synthesis, the infected cell polypeptides of HG52 and JH2604 were labelled with [35S]methionine and analysed by SDS-PAGE. There were no detectable differences between the infected cell polypeptides synthesized by HG52 and by JH2604 (data not shown).
TK assay
To determine whether the lack of neurovirulence of JH2604 was due to a mutation in TK synthesis, TK assays were performed on HG52, JH2604 and a known TK-negative mutant . The results are shown on Table 2 . With the TK-mutant the 3H c.p.m, were marginally below the background (mock-infected) levels in both experiments, while the wild-type HG52 gave counts of 3.4 and 2.4 times background levels and variant JH2604 gave counts of 3.6 and 3.0 times the mock-infected levels. Thus JH2604 is at least as efficient as HG52 in synthesizing TK.
Correction of the deletion in JH2604
Purified DNA from the neurovirulent plaque 17 of HG52 (LDs0 < 103 p.f.u.) (Taha et al., 1988) was digested with XbaI, the g, e and f fragments were excised and after purification by electroelution were used independently in cotransfection experiments with intact JH2604 DNA in order to correct the deletion in JH2604 by marker rescue. The M~ of fragment XbaI g (0.7 to 0.83 m.u.) was 13 × 10 6, that ofXbaI e (g + h 0.83 to 0.91) was 21 × 106 and off(g + i 0.94 to 1.0) was 19 × 106. In the cotransfection experiments the fragments were used at a five-, 10-and 20-fold molar excess to the intact JH2604 DNA. Although the deletion in JH2604 is only 1 × 106 M r (1.5 kb) in both copies of BamHI v, these large XbaI fragments were used to facilitate recombination between the fragment and the intact genome (the larger the fragment, the greater the chance of recombination occurring). No selection system was available to isolate the sought recombinants between the intact JH2604 genomes and the wild-type fragments.
Two-hundred plaques were picked, and the DNA of 46 of these was digested with XbaI; four of these digests showed profiles indicating that the deletion in XbaI g had been corrected, as the g, e andf bands ran in the normal wild-type position. Three were from cotransfections using a 20-fold molar excess of XbaI e and the fourth from a plate in which XbaI f had been cotransfected at a 20-fold molar excess with JH2604 DNA.
After three rounds of plaque purification, XbaI digestion confirmed that recombination had occurred and that the deletion in JH2604 had been corrected. The recombinants were design ated R 17 (192)E pl. 8, R 17( 192)E pl. 14, R l 7 (t 92)E pl. 15 and R 17(192) i I i , 
Neurovirulence of the R17(192) recombinants compared to HG52
The three-times plaque-purified recombinants were inoculated intracranially into 3-week-old BALB/c mice at titres ranging from 102 to 105 p.f.u, as described previously. As controls, the highly neurovirulent plaque 17 stock of HG52 and the JH2604 variant were used at titres ranging from 102 to 105 and 105 to 107 p.f.u, respectively. The results given in Table 3 show that all four recombinants have regained neurovirulence with somewhat variable levels ranging from 103 to 3 x 105 p.f.u. These virulence levels are within the range of the LDso levels of the individual plaque stocks of HG52 (103 to 3 x 105) (Taha et al., 1988) and suggest the occurrence of genetic variation outside the deletion region which modifies virulence. The avirulent phenotype of J H 2604 has been confirmed with an LD 5 o of > 107 p.f.u. The avirulent phenotype has therefore been corrected by insertion of wild-type sequences replacing the deletion in both copies of BamHI v.
Insertion of the deletion in JH2604 into wild-type HG52 and neurovirulence of the resulting deletion variants
Purified DNA from JH2604 was digested with XbaI, and the three fragments g, e and f containing the deletion within BamHI v were excised and purified from the gel. The three fragments were independently used in cotransfection experiments with intact D N A from H G 5 2 plaque 17 (high neurovirulence). Again, no selection system was used to isolate recombinants when 200 plaques were picked. The D N A of 40 of these was digested with XbaI ( Fig. 6) , and two showed XbaI profiles indicating that the fragments containing the deletion had recombined into the wild-type genome (lanes 2 and 3) in that the g, e and f bands were now r u n n i n g at the position of the equivalent bands in JH2604 (lane 4) and not in their normal wild-type position (lane 1). HpaI and HindlII digestion (Fig. 7) confirmed that the deletion was in both copies of RL in that HpaI g a n d f ( l a n e s 2 and 3) and HindlII i,j, c, d, f a n d g (lanes 6 and 7) were r u n n i n g below their normal wild-type positions (lanes 1 and 5). The recombinants were plaque-purified three times, their restriction profiles confirmed and virus stock was grown. The recombinants were designated RI92(17)E pl. 2 and R192(17)E pl. 5. The two recombinants R192(17)E were injected intracranially into 3-week-old BALB/c mice. Control infections with HG52 plaque 17 and JH2604 were performed at the same time. The results are shown in Table 3 . It can be seen that each of the recombinants had LDso values of > 107 p.f.u., i.e. the same as that of the non-neurovirulent deletion variant JH2604.
DISCUSSION
The nervous system is a critical target organ for HSV infection. The relationship between HSV and the peripheral nervous system is usually benign, in that the virus remains latent in the neurons of dorsal root ganglia from which it reactivates intermittently. However, when HSV invades the central nervous system the likely outcome is a fatal encephalitis. It is therefore important to determine those genes of HSV which predispose it to invade and destroy nervous tissue. Viral genes controlling neurovirulence were only identified recently, and various laboratories have predominantly implicated the viral sequences between 0.7 to 0-83 m.u. in the control of virulence (Thompson & Stevens, 1983; Thompson et al., 1985; Javier et al., 1987; Rosen et al., 1986) . This region contains the whole of IRL and part of UL. The genes encoded therein are one copy of IE1 and UL50 to UL56 (Clements et al., 1979; Perry et al., 1986; Whitton et al., 1983; McGeoch et al., 1988) . The mapping of virulence genes to this region of the genome has for the most part relied on the construction of recombinants between low and high virulence strains of HSV using specific cloned viral fragments (Thompson & Stevens, 1983; Thompson et al., 1985) . Deletion mutants in the HSV genome allow defined regions to be studied for their neurovirulence properties. A mutant of HSV-1 strain HFEM (Halliburton et al., 1980 ) with a 4 kb deletion between 0-76 and 0-79 m.u. (Rosen & Darai, 1985) has been shown to be non-pathogenic for tree shrews and mice, and its pathogenicity can be restored by the insertion of sequences spanning 0.76 to 0.79 m.u. from the pathogenic strain F (Rosen et al., 1986) .
Before studying biological properties such as latency and virulence of defined deletion variants in animal model systems, it is important to determine the phenotype of the parental wild-type virus. We have recently shown that the elite stock of HSV-2, HG52, used in our institute has an LDso of < 10 z p.f.u, on intracranial inoculation of 3-week-old BALB/c mice. However, when 10 individual plaques were isolated at random from this stock, plaque-purified three times and a virus stock was grown up from each, the LDs0 values of these 10 re-plaqued stocks exhibited individual values ranging from < 103 to 3 x l0 s p.f.u. (Taha et aL, 1988) , demonstrating a marked heterogeneity in virulence within the original unselected virus stock.
The deletion variant JH2604 has a 1.5 kb deletion in both copies of BamHI v. As no sequencing data for this region of HG52 are available, the location of the deletion relied solely on restriction endonuclease analysis. The same sequences could be deleted from each copy but the size of the deletion and the size of BamHI v (3 kb) does not preclude the deleted sequences being at least in part contiguous (Harland & Brown, 1985) . The results presented in this paper have demonstrated that JH2604 is avirulent on intracranial inoculation of 3-week-old BALB/c mice (LCs0 > 107 p.f.u.) compared with the plaque-purified plaque 17 stock of HG52 (< 103). JH2604 and its parental HG52 grew equally well in BHK-21 C-13 cells at 37 °C and JH2604 is no more temperature-restricted at 38-5 °C than HG52. The variant failed to grow in BALB/c micederived 3T3 cells at both 37 °C and 38.5 °C, but as the wild-type showed poor replication in these cells the significance of apparent lack of growth of JH2604 is unclear. Of more importance is the finding that JH2604 does not replicate in vivo in mouse brain. The wild-type virus grows well within the brain at the accepted ambient mouse temperature of 38.5 °C, reaching peak titres by 120 h post-infection with all the experimentally infected animals dying by 144 h post-infection. JH2604 showed some replication by 12 and 24 h, but by 48 h the amount of infectious virus recoverable from infected brains was over 1 loglo unit lower than the input virus measurable immediately post-absorption. Viral functions required for neurovirulence may modify the process in a variety of ways, e.g. by affecting replication at the peripheral site, at neural entry, spread within the nervous system and by facilitating escape from immunological surveillance.
The intracranial route of inoculation, although artificial, has the advantage of bypassing most of these steps. The brain pathology induced by HG52 and the JH2604 variant has been studied and is being reported in a separate communication; suffice to say that JH2604-infected brains demonstrate no gross pathology.
The TK phenotype of the variant JH2604 when compared to that of the parental HG52 was found to be equally efficient. The low neurovirulence and lack of growth in mouse brain is therefore not a result of the virus being TK-. Support for this conclusion comes from the finding that JH2604 is capable of establishing latency in the dorsal root ganglia of mice (G. B. Clements, unpublished data).
Cotransfection of intact DNA of JH2604 and XbaI fragments of HG52 plaque 17 containing sequences deleted from JH2604 resulted in the isolation of recombinants in which the deleted sequences had been replaced by equivalent sequences from the XbaI fragment. The isolation of the recombinants enabled us to determine whether the replaced sequences had a direct effect on neurovirulence. From 28 mice infected with R 17(192)E pl. 8, the LDs0 value of the recombinant was calculated to be 2 x 105 p.f.u. ; from 40 mice infected with R17(192)E pl. 14, 1 x 103 p.f.u.; from 28 infected with R17(192)Epl.15, 3xl05p.f.u.; and from 46 infected with R17(192)F pl. 10, 3 x 105 p.f.u. These values are within the range (103 to 3 x 10 s) of the individual plaque stocks of HG52 (Taha et al., 1988) . The deletion in JH2604 was corrected by the use of fragments from the neurovirulent plaque 17 of HG52 (LDs0 < 103). The range of LDso values obtained with the recombinants in which the deletion has been corrected suggest either that (i) there are sequences apart from those deleted in JH2604 which act either in conjunction with or independently of those between 0 to 0.02 and 0.81 to 0.83 m.u. to determine neurovirulence or (ii) the DNA stock of HG52 plaque 17 is heterogeneous, in that viruses arising from individual genomes have different virulence potentials. The latter would mean that the virus population of HG52 plaque 17 despite its recent purification contains a genome mixture with virulence LDso values similar to those of the individual plaque stocks of the elite HG52 laboratory stock (< 103 to 3 X 105). To determine whether this was the case, a DNA stock of HG52 pl. 17 was transfected and five well separated progeny plaques were isolated. Virus stocks from the five plaques were inoculated into mice as before and the LDso values were determined for each; these values were <102, <103, 104 and >104 p.f.u., confirming the virulence heterogeneity within the stock of HG52 pl. 17. However, the deaths of 10/33 animals infected with the R17(192) recombinants at a dose of 10 s p.f.u, and 10/15 with 106 p.f.u, compared to 0/12 with 10 s p.f.u., 0/12 with 106 p.f.u, and 2/18 with 107 p.f.u, of JH2604 point to the avirulent phenotype having been corrected by the replacement of the deleted sequences within both copies of BamHI v, or the exchange of sequences with the remainder of XbaI e. It would have been more critical to correct the deletion by cotransfecting with the BamHI g joint fragment (v + u), but because this fragment is so small (4 x 106 Mr) and no selection system was available, we chose to facilitate recombination by using XbaI fragments. It could be argued that as well as replacing the deleted sequences the recombinant could also have other sequences from XbaI e of HG52 plaque 17. This could of course imply that apart from the deletion the sequences within XbaI e of JH2604 and XbaI e of HG52 plaque 17 are not equivalent and affect neuropathogenicity.
The isolation of two recombinants in which the deletion in JH2604 has been introduced into the HG52 plaque 17 stock allowed the determination of whether the reciprocal recombinants to those isolated previously behaved differently upon inoculation into mice. Intracranial inoculation of 18 mice with each recombinant produced an LDs0 value of > 107 p.f.u, in each case. This is identical to the LDso value determined from 42 animals infected at the same time with JH2604. These results provide substantive evidence that the sequences deleted in JH2604 are involved in the determination of neurovirulence of HSV-2 HG52.
BamHI v of HG52 co-maps with BamHI s of HSV-1. The nucleotide sequence of v is not known, but in HSV-1 strain 17 no complete genes have been identified in BamHI s. The 5' end and 500 bp from that end of the immediate early gene IE1 are located within BamHI s, the BamHI s/b site being located within the first intron of the gene (McGeoch et al., 1988) . We have shown previously that JH2604 makes VmwlEll8 of normal size and in normal amounts In vivo analysis of the HG52 deletion variant JH2604 has demonstrated that at least 500 bp and at most 1500 bp of the terminal sequences of RL are required to confer neurovirulence. As no genes have as yet been identified in this region it must be assumed that the deleted sequences have a control function. Sequence analysis of RE in HG52 and JH2604 should help to clarify their precise role.
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